山东大学学报 (医学版) ›› 2018, Vol. 56 ›› Issue (9): 47-53.doi: 10.6040/j.issn.1671-7554.0.2018.512
• • 上一篇
范华蕊,张洋,郭情情,李福侠,唐蓉,盛燕,丁玲玲,秦莹莹
FAN Huarui, ZHANG Yang, GUO Qingqing, LI Fuxia, TANG Rong, SHENG Yan, DING Lingling, QIN Yingying
摘要: 目的 分析2008~2017年10年间行体外受精(IVF)/卵胞浆内单精子显微注射(ICSI)周期取消新鲜胚胎移植的原因构成及变化。 方法 回顾性分析2008年至2017年取消新鲜胚胎移植的17 601个IVF/ICSI周期,其中2008年至2012年3 018个周期、2013年至2017年14 583个周期,根据取消原因分为预防卵巢过度刺激综合征(OHSS)、注射人绒毛膜促性腺激素(HCG)日孕酮值升高、子宫内膜因素、胚胎因素、输卵管积水及其他因素,分析10年间取消鲜胚移植的原因构成比,并进一步按女性不同年龄组(≥35岁和<35岁)及不同用药方案进行分层分析。 结果 IVF/ICSI取消新鲜胚胎移植的主要原因是OHSS风险,近10年在各年龄组发生率均有上升趋势。≥35岁患者取消移植的主要原因是胚胎因素,<35岁患者取消移植的主要原因是OHSS风险。因输卵管积水取消鲜胚移植的比例近10年在各年龄组中均有增加。长方案、拮抗剂方案及超长方案取消鲜胚移植的主要原因是预防OHSS,短方案、微刺激方案主要原因是胚胎因素。 结论 目前IVF/ICSI取消鲜胚移植的主要原因是OHSS风险,其次为胚胎因素、内膜因素。年龄越大,胚胎原因取消移植所占比例越高。有效预防卵巢高反应、提高高龄女性胚胎质量、积极控制盆腔炎症是降低鲜胚移植取消率、改善辅助生殖技术妊娠结局的有效措施。
中图分类号:
[1] 徐蓓, 靳镭. 在高反应人群中如何预防卵巢过度刺激综合征[J]. 生殖医学杂志, 2017, 26(11): 1071-1074. XU Bei, JIN Lei. How to prevent OHSS in patients with high ovarian response?[J]. Journal of Reproductive Medicine, 2017, 26(11): 1071-1074. [2] Lawrenz B, Labarta E, Fatemi H, et al. Premature progesterone elevation: targets and rescue strategies[J]. Fertil Steril, 2018, 109(4): 577-582. [3] 陈子江, 刘新民, 李媛, 等. 人类生殖与辅助生殖[M]. 北京: 科学出版社, 2005: 701-702. [4] 刘平, 乔杰. 生殖医学实验室技术[M]. 北京: 北京大学医学出版社, 2013: 106-109. [5] Griesinger G, Verweij PJ, Gates D, et al. Prediction of ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or rFSH in a GnRH antagonist protocol[J]. PLoS One, 2016, 11(3): e0149615. doi: 10.1371/journal.pone.0149615. [6] Mourad S, Brown J, Farquhar C. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews[J]. Cochrane Database Syst Rev, 2017, 1: CD012103. doi: 10.1002/14651858.CD012103.pub2. [7] Lambalk CB, Banga FR, Huirne JA, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type[J]. Hum Reprod Update, 2017, 23(5): 560-579. [8] Wang R, Lin S, Wang Y, et al. Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: a systematic review and meta-analysis[J]. PLoS One, 2017, 12(4): e0175985. doi: 10.1371/journal.pone.0175985. [9] Dosouto C, Haahr T, Humaidan P. Gonadotropin-releasing hormone agonist(GnRHa)trigger-State of the art[J]. Reprod Biol, 2017, 17(1): 1-8. [10] Dahan MH, Tannus S, Seyhan A, et al. Combined modalities for the prevention of ovarian hyperstimulation syndrome following an excessive response to stimulation[J]. Gynecol Endocrinol, 2018, 34(3): 252-255. [11] Fatemi HM, Garcia-Velasco J. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone trigger[J]. Fertil Steril, 2015, 103(4): 870-873. [12] Ashmita J, Vikas S, Swati G. The impact of progesterone level on day of HCG injection in IVF cycles on clinical pregnancy rate[J]. J Hum Reprod Sci, 2017, 10(4): 265-270. [13] Venetis CA, Kolibianakis EM, Bosdou JK, et al. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles[J]. Hum Reprod, 2015, 30(3): 684-691. [14] Bu Z, Zhao F, Wang K, et al. Serum progesterone elevation adversely affects cumulative live birth rate in different ovarian responders during in vitro fertilization and embryo transfer: a large retrospective study[J]. PLoS One, 2014, 9(6): e100011. doi: 10.1371/journal.pone.0100011. [15] 刁俊荣, 张云山, 杜爱军, 等. HCG日孕酮升高对妊娠结局的影响及其早期预测因素的探讨[J]. 实用妇产科杂志, 2016, 32(1): 33-37. DIAO Junrong, ZHANG Yunshan, DU Aijun, et al. The impact of elevated progesterone on the day of HCG administration on pregnancy outcomes and its early prognostic factors[J]. Journal of Practical Obstetrics and Gynecology, 2016, 32(1): 33-37. [16] Wang A, Santistevan A, Hunter Cohn K, et al. Freeze-only versus fresh embryo transfer in a multicenter matched cohort study: contribution of progesterone and maternal age to success rates[J]. Fertil Steril, 2017, 108(2): 254-261. [17] Healy MW, Patounakis G, Connell MT, et al. Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles?[J]. Fertil Steril, 2016, 105(1): 93-99.e1. [18] 李元, 龚斐. GnRH-a促排周期中晚卵泡期孕酮上升的原因与策略[J]. 生殖医学杂志, 2017, 26(11): 1095-1099. LI Yuan, GONG Fei. The causes and countermeasures of premature elevation during the late follicular phase in GnRH-agonist cycles[J]. Journal of Reproductive Medicine, 2017, 26(11): 1095-1099. [19] Gingold JA, Lee JA, Rodriguez-Purata J, et al. Endometrial pattern, but not endometrial thickness, affects implantation rates in euploid embryo transfers[J]. Fertil Steril, 2015, 104(3): 620-628.e5. [20] Ribeiro VC, Santos-Ribeiro S, De Munck N, et al. Should we continue to measure endometrial thickness in modern-day medicine? The effect on live birth rates and birth weight[J]. Reprod Biomed Online, 2018, 36(4): 416-426. [21] Amir W, Micha B, Ariel H, et al. Predicting factors for endometrial thickness during treatment with assisted reproductive technology[J]. Fertil Steril, 2007, 87(4): 799-804. [22] Erel CT, Aydin Y, Kaleli S, et al. Is endometrial apoptosis evidence of endometrial aging in unexplained infertility? a preliminary report[J]. Eur J Obstet Gynecol Reprod Biol, 2005, 121(2): 195-201. [23] 刘芳, 高婷婷, 巨瑛, 等. 输卵管积水性不孕行新鲜胚胎移植的妊娠结局分析[J]. 中国妇幼健康研究, 2016, 27(7): 853-855. LIU Fang, GAO Tingting, JU Ying, et al. Pregnancy outcomes of fresh embryo transplantation in hydrosalpinx induced infertility patients[J]. Chinese Journal of Woman and Child Health Research, 2016, 27(7): 853-855. [24] Sharma JB, Sneha J, Singh UB, et al. Comparative study of laparoscopic abdominopelvic and fallopian tube findings before and after antitubercular therapy in female genital tuberculosis with infertility[J]. J Minim Invasive Gynecol, 2016, 23(2): 215-222. [25] Tsiami A, Chaimani A, Mavridis D, et al. Surgical treatment for hydrosalpinx prior to in-vitro fertilization embryo transfer: a network meta-analysis[J]. Ultrasound Obstet Gynecol, 2016, 48(4): 434-445. [26] 吴佘玲, 唐蓉, 范秀玲, 等. 输卵管积水不同处理方式对体外受精-胚胎移植结局的影响: 一项回顾性队列研究[J]. 中华生殖与避孕杂志, 2018, 38(1): 11-15. WU Sheling, TANG Rong, FAN Xiuling, et al. Effects of different operation managements on in vitro fertilization and embryo transfer outcome: a retrospective cohort study[J]. Chinese Journal of Reproduction and Contraception, 2018, 38(1): 11-15. |
[1] | 颜磊,岳彩欣,刘懿淳. 子宫内膜异位症的生育力保护[J]. 山东大学学报 (医学版), 2022, 60(9): 31-34. |
[2] | 鹿群,赵璐璐. 子宫内膜癌、子宫内膜非典型增生保留生育功能后助孕策略[J]. 山东大学学报 (医学版), 2022, 60(9): 35-41. |
[3] | 赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58. |
[4] | 刘腾,马迎春. 基于生物信息库病例分析ECT2在子宫内膜癌中的表达及临床意义[J]. 山东大学学报 (医学版), 2022, 60(8): 63-71. |
[5] | 冷金花,史精华. 子宫腺肌病的临床表现[J]. 山东大学学报 (医学版), 2022, 60(7): 1-5. |
[6] | 申晓畅,孙一卿,颜磊,赵兴波. 芳基烃受体核转位因子样蛋白2在子宫内膜癌中的表达[J]. 山东大学学报 (医学版), 2022, 60(5): 74-80. |
[7] | 陈忠绍,褚然,李明宝,张向宁. MRKH综合征相关腹股沟子宫疝修补术后腹壁瘢痕子宫内膜异位症1例报道并文献复习[J]. 山东大学学报 (医学版), 2022, 60(5): 114-117. |
[8] | 徐歌,李青,张灿灿,田永杰. 子宫腺肌病组织及原代细胞中PARP-1、HIF-1α的表达及临床意义[J]. 山东大学学报 (医学版), 2022, 60(4): 55-61. |
[9] | 林雪艳,张灿灿,田民乐,田永杰. 聚腺苷酸二磷酸核糖聚合酶-1在子宫内膜异位症中的表达及意义[J]. 山东大学学报 (医学版), 2022, 60(2): 27-31. |
[10] | 单婧,王晓秋,李大金. NK细胞参与子宫内膜异位症及其不孕的分子机制[J]. 山东大学学报 (医学版), 2021, 59(8): 8-13. |
[11] | 杨岫岩,张建瑜. 从风湿免疫角度谈生殖免疫的一些思路[J]. 山东大学学报 (医学版), 2021, 59(8): 20-23. |
[12] | 丁菲,姜洁. 姜黄素对子宫内膜癌孕激素抵抗的影响[J]. 山东大学学报 (医学版), 2021, 59(4): 35-41. |
[13] | 梁炎春,叶海花,陆丽美,戴郁菁,程谦益,蔡婉玲,曾涵秋,陈杏欢,王兴,韦雅婧,杨如玉. 慢性子宫内膜炎对子宫内膜异位症相关性不孕妊娠结局的影响[J]. 山东大学学报 (医学版), 2021, 59(3): 55-59. |
[14] | 薛源,林雪艳,徐歌,田永杰. 低氧诱导因子-1α在子宫内膜异位症患者血清中的表达和对在位子宫内膜间质细胞上皮-间质转化的影响[J]. 山东大学学报 (医学版), 2021, 59(2): 41-47. |
[15] | 潘虹江,王焕昇,裴发军,杨明山. 孤立性膀胱子宫内膜异位症1例[J]. 山东大学学报 (医学版), 2021, 59(2): 122-124. |
|